ARTICLE AD BOX
S. Korea's biopharmaceutical company said that its sales amounted to $840 million in the second quarter of this year, up 35.2% from a year earlier.
S. Korea's biopharmaceutical company said that its sales amounted to $840 million in the second quarter of this year, up 35.2% from a year earlier.